We are live on
!
Find out more
GA
General Atlantic Portfolio holdings
AUM
$2.15B
1-Year Est. Return
35.02%
This Fund
S&P 500
This Quarter
Est. Return
-1.94%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$3.18B
AUM Growth
-$1.13B
(-26%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-19.38%
Top 10 Holdings %
Top 10 Hldgs %
94.18%
Holding
22
New
–
Increased
–
Reduced
2
Closed
3
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HRT
HireRight Holdings Corporation
HRT
|
+$458M |
| 2 |
HUTCHMED
HCM
|
+$67.2M |
| 3 |
Alkami Technology
ALKT
|
+$39.8M |
| 4 |
Mobileye
MBLY
|
+$38.4M |
| 5 |
Immunocore
IMCR
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.7% |
| 2 | Healthcare | 30.29% |
| 3 | Financials | 16.38% |
| 4 | Consumer Staples | 4.15% |
| 5 | Real Estate | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
XP
XP
$8.41B
| $521M | 16.38% |
29,617,733
| – | – |
|
2
dLocal
DLO
$4.28B
| $517M | 16.26% |
63,906,695
| – | – |
|
|
3
Alkami Technology
ALKT
$1.97B
| $489M | 15.39% |
17,186,985
-1,542,821
| -8% | -$39.8M |
|
4
Alignment Healthcare
ALHC
$3.81B
| $477M | 15% |
60,993,323
| – | – |
|
|
SQSP
5
DELISTED
Squarespace, Inc.
SQSP
| $463M | 14.56% |
10,611,073
| – | – |
|
6
Pharvaris
PHVS
$2.26B
| $142M | 4.45% |
7,531,252
| – | – |
|
|
EWCZ
7
DELISTED
European Wax Center
EWCZ
| $130M | 4.09% |
13,110,492
| – | – |
|
|
AKRO
8
DELISTED
Akero Therapeutics
AKRO
| $123M | 3.86% |
5,233,989
| – | – |
|
|
CNTA
9
DELISTED
Centessa Pharmaceuticals
CNTA
| $87.4M | 2.75% |
9,681,818
| – | – |
|
10
Blend Labs
BLND
$436M
| $45.2M | 1.42% |
19,132,440
| – | – |
|
|
11
Immunocore
IMCR
$1.68B
| $42.8M | 1.34% |
1,261,684
-245,000
| -16% | -$12.5M |
|
12
Royalty Pharma
RPRX
$26.7B
| $39.6M | 1.24% |
1,500,000
| – | – |
|
|
THRD
13
DELISTED
Third Harmonic Bio
THRD
| $38.5M | 1.21% |
2,958,762
| – | – |
|
14
Riskified
RSKD
$727M
| $34M | 1.07% |
5,324,998
| – | – |
|
|
SLRN
15
DELISTED
ACELYRIN
SLRN
| $12.7M | 0.4% |
2,889,668
| – | – |
|
16
Opendoor
OPEN
$3.68B
| $11.6M | 0.37% |
6,532,236
| – | – |
|
|
LOGC
17
DELISTED
ContextLogic
LOGC
| $3.48M | 0.11% |
609,616
| – | – |
|
18
Grove Collaborative
GROV
$45.4M
| $1.66M | 0.05% |
936,020
| – | – |
|
|
ADAG
19
Adagene
ADAG
$242M
| $808K | 0.03% |
264,000
| – | – |
|
|
20
HUTCHMED
HCM
$1.95B
| – | – |
-4,000,000
| Closed | -$67.2M |
|
|
21
Mobileye
MBLY
$2.03B
| – | – |
-1,194,839
| Closed | -$38.4M |
|
|
HRT
22
DELISTED
HireRight Holdings Corporation
HRT
| – | – |
-32,109,898
| Closed | -$458M |
|
Similar funds
NAAA
MA
SC
IIP
CI
AAP
RFP
TAL
General Atlantic's Q2 2024 Portfolio in Review
As of Q2 2024, General Atlantic held 22 positions worth $3.18B, down 26% from $4.31B the previous quarter. Its ten largest holdings account for 94% of the portfolio.
General Atlantic withdrew a net $616M in Q2 2024, closing 3 positions and reducing 2 holdings. Its most notable exit was HireRight Holdings Corporation, an estimated $458M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 44% a quarter earlier, followed by Healthcare and Financials.
- General Atlantic's biggest Q2 2024 reduction was Alkami Technology, cutting an estimated $39.8M.
- General Atlantic fully exited HireRight Holdings Corporation in Q2 2024, selling an estimated $458M.
- General Atlantic's ten largest holdings make up 94% of its $3.18B portfolio in Q2 2024.
- General Atlantic opened 0 new positions and closed 3 in Q2 2024.
- General Atlantic's portfolio value fell 26% quarter-over-quarter to $3.18B.
Based on General Atlantic's 13F filing for Q2 2024, filed 14 Aug 2024.